trending Market Intelligence /marketintelligence/en/news-insights/trending/4ya7ciak1jcdbfj-htiqyw2 content esgSubNav
In This List

Retrophin CEO plans to retire

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Retrophin CEO plans to retire

Retrophin Inc. said Stephen Aselage plans to retire as CEO.

Aselage, who has been CEO since November 2014, will step down after the company identifies his successor.

Retrophin's board has initiated a global search for his successor that will include both internal and external candidates.

San Diego, Calif.-based Retrophin develops treatments for serious or rare diseases. Martin Shkreli, who was convicted of securities fraud in March, is the company's co-founder and former CEO.